Bill Few Associates’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $221K | Sell |
3,200
-150
| -4% | -$10.4K | 0.06% | 181 |
|
|
2025
Q1 | $233K | Buy |
3,350
+100
| +3% | +$6.94K | 0.08% | 156 |
|
|
2024
Q4 | $280K | Sell |
3,250
-100
| -3% | -$8.6K | 0.1% | 142 |
|
|
2024
Q3 | $399K | Hold |
3,350
| – | – | 0.14% | 116 |
|
|
2024
Q2 | $478K | Buy |
3,350
+400
| +14% | +$57.1K | 0.18% | 99 |
|
|
2024
Q1 | $379K | Buy |
2,950
+550
| +23% | +$70.6K | 0.15% | 108 |
|
|
2023
Q4 | $248K | Hold |
2,400
| – | – | 0.11% | 130 |
|
|
2023
Q3 | $218K | Buy |
+2,400
| New | +$218K | 0.11% | 125 |
|